These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28277060)

  • 1. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial.
    Rafiq S; Johansson PI; Kofoed KF; Lund JT; Olsen PS; Bentsen S; Steinbrüchel DA
    Platelets; 2017 Dec; 28(8):786-793. PubMed ID: 28277060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
    Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
    Trials; 2012 Apr; 13():48. PubMed ID: 22540524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    Gao C; Ren C; Li D; Li L
    Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulability in relation to coronary artery bypass graft patency and clinical outcome.
    Zacho M; Rafiq S; Kelbæk H; Johansson PI; Nielsen MB; Steinbrüchel DA; Kofoed KF
    Scand Cardiovasc J; 2013 Apr; 47(2):104-8. PubMed ID: 23205579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
    Verma S; Goodman SG; Mehta SR; Latter DA; Ruel M; Gupta M; Yanagawa B; Al-Omran M; Gupta N; Teoh H; Friedrich JO
    BMC Surg; 2015 Oct; 15():112. PubMed ID: 26467661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
    Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome.
    Rafiq S; Johansson PI; Ostrowski SR; Stissing T; Steinbrüchel DA
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):550-5. PubMed ID: 22011771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of aspirin and clopidogrel after coronary artery bypass graft surgery.
    de Leon N; Jackevicius CA
    Ann Pharmacother; 2012 May; 46(5):678-87. PubMed ID: 22570427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
    Wang A; Wu A; Wojdyla D; Lopes RD; Newby LK; Newman MF; Smith PK; Alexander JH
    Am Heart J; 2018 May; 199():150-155. PubMed ID: 29754654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.
    Chakos A; Jbara D; Singh K; Yan TD; Tian DH
    Ann Cardiothorac Surg; 2018 Sep; 7(5):577-585. PubMed ID: 30505741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.
    Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M
    Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.
    Harskamp RE; Beijk MA; Damman P; Tijssen JG; Lopes RD; de Winter RJ
    Am J Cardiol; 2013 Jan; 111(2):153-8. PubMed ID: 23102882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
    Ebrahimi R; Bakaeen FG; Uberoi A; Ardehali A; Baltz JH; Hattler B; Almassi GH; Wagner TH; Collins JF; Grover FL; Shroyer AL
    Ann Thorac Surg; 2014 Jan; 97(1):15-21. PubMed ID: 24206971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.
    Bayam E; Öztürkeri B; Yıldırım E; Kalçık M; Küp A; Çakmak EÖ; Günay N; Güner A; Kalkan S; Karaduman A; Kahyaoğlu M; Zehir R
    Acta Cardiol; 2021 Sep; 76(7):785-791. PubMed ID: 33880976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.